Follow
Christopher Sinal
Christopher Sinal
Verified email at dal.ca - Homepage
Title
Cited by
Cited by
Year
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal, M Tohkin, M Miyata, JM Ward, G Lambert, FJ Gonzalez
Cell 102 (6), 731-744, 2000
20002000
Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism
KB Goralski, TC McCarthy, EA Hanniman, BA Zabel, EC Butcher, ...
Journal of Biological Chemistry 282 (38), 28175-28188, 2007
11702007
Chemerin: at the crossroads of inflammation and obesity
MC Ernst, CJ Sinal
Trends in Endocrinology & Metabolism 21 (11), 660-667, 2010
6572010
Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program
S Muruganandan, AA Roman, CJ Sinal
Cellular and molecular life sciences 66, 236-253, 2009
5872009
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
G Lambert, MJA Amar, G Guo, HB Brewer, FJ Gonzalez, CJ Sinal
Journal of Biological Chemistry 278 (4), 2563-2570, 2003
4812003
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450
EG Schuetz, S Strom, K Yasuda, V Lecureur, M Assem, C Brimer, ...
Journal of Biological Chemistry 276 (42), 39411-39418, 2001
4512001
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
Y Zhang, LW Castellani, CJ Sinal, FJ Gonzalez, PA Edwards
Genes & development 18 (2), 157-169, 2004
4462004
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer
ET Morgan, KB Goralski, M Piquette-Miller, KW Renton, GR Robertson, ...
Drug Metabolism and Disposition 36 (2), 205-216, 2008
4402008
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal, M Miyata, M Tohkin, K Nagata, JR Bend, FJ Gonzalez
Journal of Biological Chemistry 275 (51), 40504-40510, 2000
4272000
Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids
HR Kast, CM Nguyen, CJ Sinal, SA Jones, BA Laffitte, K Reue, ...
Molecular endocrinology 15 (10), 1720-1728, 2001
4132001
Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity
GL Guo, G Lambert, M Negishi, JM Ward, HB Brewer, SA Kliewer, ...
Journal of Biological Chemistry 278 (46), 45062-45071, 2003
3632003
Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes
MC Ernst, M Issa, KB Goralski, CJ Sinal
Endocrinology 151 (5), 1998-2007, 2010
3592010
Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells
CJ Sinal, JR Bend
Molecular pharmacology 52 (4), 590-599, 1997
3451997
Towards an integrative approach to understanding the role of chemerin in human health and disease
JL Rourke, HJ Dranse, CJ Sinal
Obesity Reviews 14 (3), 245-262, 2013
3242013
Liver receptor homologue-1 mediates species-and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter
F Chen, L Ma, PA Dawson, CJ Sinal, E Sehayek, FJ Gonzalez, J Breslow, ...
Journal of Biological Chemistry 278 (22), 19909-19916, 2003
3072003
Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-α
SD Parlee, MC Ernst, S Muruganandan, CJ Sinal, KB Goralski
Endocrinology 151 (6), 2590-2602, 2010
2662010
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
JM Seubert, CJ Sinal, J Graves, LM DeGraff, JA Bradbury, CR Lee, ...
Circulation research 99 (4), 442-450, 2006
2362006
Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells
S Muruganandan, AA Roman, CJ Sinal
Journal of Bone and Mineral Research 25 (2), 222-234, 2010
2302010
Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance
MC Ernst, ID Haidl, LA Zúñiga, HJ Dranse, JL Rourke, BA Zabel, ...
Endocrinology 153 (2), 672-682, 2012
2082012
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
EA Hanniman, G Lambert, TC McCarthy, CJ Sinal
Journal of lipid research 46 (12), 2595-2604, 2005
2042005
The system can't perform the operation now. Try again later.
Articles 1–20